Sumgen Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 22

Employees

  • Latest Deal Type
  • Series C

  • Investors
  • 18

Sumgen General Information

Description

Developer of innovative antibody drugs designed for the treatment of tumors and other diseases. The company offers computer-aided design combined with mammalian cell display technology to screen and optimize antibody drugs for individual candidates and create effective antibody drugs, thereby enabling patients to receive treatment for major diseases such as cancer.

Contact Information

Website
sumgenbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1st Floor, Building C, Number 688 Bin'an Road, Changhe Street
  • Binjiang District
  • Hangzhou, Zhejiang 310050
  • China
+86 188
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 1st Floor, Building C, Number 688 Bin'an Road, Changhe Street
  • Binjiang District
  • Hangzhou, Zhejiang 310050
  • China
+86 188

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sumgen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series C) 25-Dec-2025 Completed Generating Revenue
8. Secondary Transaction - Private 06-Dec-2024 Completed Generating Revenue
7. Later Stage VC (Series B1) 29-Dec-2021 Completed Generating Revenue
6. Later Stage VC (Series B) 12-Sep-2020 Completed Generating Revenue
5. Early Stage VC 31-Mar-2019 Completed Generating Revenue
4. Early Stage VC (Series A1) 01-Jan-2019 Completed Generating Revenue
3. Early Stage VC (Series A) 01-Jun-2018 Completed Generating Revenue
2. Early Stage VC 06-Sep-2017 Completed Generating Revenue
1. Early Stage VC 01-Mar-2017 Completed Clinical Trials - General
To view Sumgen’s complete valuation and funding history, request access »

Sumgen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sumgen Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Beijing Qijian Private Equity Fund Management Growth/Expansion Minority
Chime Biologics VC-Backed Company Minority
Oriental Fortune Capital Venture Capital Minority
Shanghai Sitong Private Equity Fund Management Venture Capital Minority
Shenzhen Qianhai Junchuan Investment Growth/Expansion Minority
You’re viewing 5 of 18 investors. Get the full list »

Sumgen FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process